About Nephrosant
Nephrosant is a company based in San Francisco (United States) founded in 2017 by Minnie Sarwal and Joshua Young Yang.. Nephrosant has raised $16 million across 1 funding round from investors including DaVita Venture Group and DigitalDX Ventures. The company has 49 employees as of December 31, 2021. Nephrosant operates in a competitive market with competitors including Oxford Immunotec, Immucor, Verici Dx, Olaris and Transplant Genomics, among others.
- Headquarter San Francisco, United States
- Employees 49 as on 31 Dec, 2021
- Founders Minnie Sarwal, Joshua Young Yang
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Nephrosant, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$16 M (USD)
in 1 rounds
-
Latest Funding Round
$16 M (USD), Series A
Mar 16, 2021
-
Investors
DaVita Venture Group
& 1 more
-
Employee Count
49
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Nephrosant
Nephrosant has successfully raised a total of $16M through 1 strategic funding round. The most recent funding activity was a Series A round of $16 million completed in March 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $16.0M
-
First Round
First Round
(16 Mar 2021)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2021 | Amount | Series A - Nephrosant | Valuation | DaVita Venture Group |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Nephrosant
Nephrosant has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include DaVita Venture Group and DigitalDX Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm investing in healthcare sectors
|
Founded Year | Domain | Location | |
|
DigitalDX Ventures is focused on AI and healthcare innovation investments.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Nephrosant
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Nephrosant
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Nephrosant Comparisons
Competitors of Nephrosant
Nephrosant operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Oxford Immunotec, Immucor, Verici Dx, Olaris and Transplant Genomics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Immune markers are utilized by Oxford Immunotec for disease diagnostics.
|
|
| domain | founded_year | HQ Location |
Transfusion and transplantation diagnostic products are provided by Immucor.
|
|
| domain | founded_year | HQ Location |
Developer of diagnostic solutions for organ transplants
|
|
| domain | founded_year | HQ Location |
In-vitro diagnostics are developed for oncology, transplants, and neurodegeneration.
|
|
| domain | founded_year | HQ Location |
Molecular diagnostic tests for early graft injury detection are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Nephrosant
Frequently Asked Questions about Nephrosant
When was Nephrosant founded?
Nephrosant was founded in 2017 and raised its 1st funding round 4 years after it was founded.
Where is Nephrosant located?
Nephrosant is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Who is the current CEO of Nephrosant?
Minnie Sarwal is the current CEO of Nephrosant. They have also founded this company.
Is Nephrosant a funded company?
Nephrosant is a funded company, having raised a total of $16M across 1 funding round to date. The company's 1st funding round was a Series A of $16M, raised on Mar 16, 2021.
How many employees does Nephrosant have?
As of Dec 31, 2021, the latest employee count at Nephrosant is 49.
What does Nephrosant do?
Nephrosant was founded in 2017 in San Francisco, United States, within the biotechnology sector. Diagnostic tools for kidney disorders are created by the company, with operations centered on early detection of transplant rejection. The primary product, QiSant, is utilized to produce a quantitative Q-Score that assesses rejection risk. Leadership is provided by co-founders Minnie Sarwal, serving as CEO, and Joshua Young Yang. The domain nephrosant.com supports these activities.
Who are the top competitors of Nephrosant?
Nephrosant's top competitors include Olaris, Oxford Immunotec and Verici Dx.
Who are Nephrosant's investors?
Nephrosant has 2 investors. Key investors include DaVita Venture Group, and DigitalDX Ventures.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.